Elevated NO levels in the tumor microenvironment and enhanced inducible NO synthase (iNOS) activity have been associated with elevated anti-tumor activity in a wide array of in vitro models, including pancreatic cancer cell lines, human ovarian cancer cell lines, rodent colon, breast models, and hepatic sarcoma metastases [15]. This evidence concerns the gene NOS2 and liver sarcoma.